News
VIA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Via Transportation (VIA) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Via Transportation To Contact Him Directly To Discuss Their Options If you purchased
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
International Paper Announces Changes to Its Board of Directors
Katherine Collins and Lori J. Ryerkerk to Join as Newest Board Members Directors Dr. Kathryn Sullivan and Ahmet C.
WGS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their Options If you purchased or acquired
VRRM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Verra (VRRM) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Verra To Contact Him Directly To Discuss Their Options If you purchased or acquired s
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
AeroVironment, Inc. Notice of July 27, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
Safehold Sets Second Quarter 2026 Earnings Release Date and Webcast
NEW YORK, July 17, 2026 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE) announced today that it will release its financial results for the second quarter 2026 after the market close on Thursday, July 30, 2
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ – VALU ) announced today that its Board of Directors declared on July 17, 2026 a quarterly cash dividend of $0.35 per common share,
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ - VALU) announced today that its Board of Directors declared on July 17, 2026 a quarterly cash dividend of $0. 35 per common share,
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regula
4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif. , July 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted
Vaxart Announces Results of Annual Meeting of Stockholders
SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pi
Immuneering Corporation Announces Grants of Inducement Awards
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, previously
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. , July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regul
MaxsMaking Inc. Notified of Anticipated Delisting from The Nasdaq Stock Market
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified MaxsMaking Inc. (Nasdaq: MAMK) that its securities will be delisted from the Nas
CCSC Technology International Holdings Limited Reports Financial Results for Fiscal Year Ended March 31, 2026
HONG KONG, July 17, 2026 /PRNewswire/ -- CCSC Technology International Holdings Limited (the "Company" or "CCSC") (Nasdaq: CCTG), a Hong Kong-based company that engages in the sale, design and manufac
Immuneering Corporation Announces Grants of Inducement Awards
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, previously
Paramount Skydance Corporation Announces Extension of Expiration Dates of Previously Announced Exchange Offers and Tender Offers
LOS ANGELES and NEW YORK, July 17, 2026 /PRNewswire/ -- Paramount Skydance Corporation (NASDAQ: PSKY) ("Paramount") today announced the extension of the Expiration Dates in connection with the previou
Vaxart Announces Results of Annual Meeting of Stockholders
SOUTH SAN FRANCISCO, Calif. , July 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing a range of oral recombinant p
